![](/img/cover-not-exists.png)
1129PWindow of opportunity for durvalumab (MEDI4736) plus metformin trial in squamous cell carcinoma of the head and neck (SCCHN): Interim safety analysis
Richa, T, Johnson, J M, Cognetti, D M, Argiris, A, Luginbuhl, A, Zinner, R, Axelrod, R, Bar-Ad, V, Goldman, R, Rodeck, U, Martinez-Outschoorn, U, Curry, J MVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz252.021
Date:
October, 2019
File:
PDF, 84 KB
2019